Estònia - estonià - Ravimiamet

takeda pharma as - karbamasepiin - tablett - 200mg 50tk

Unió Europea - estonià - EMA (European Medicines Agency)

amgen europe b.v. - blinatumomab - prekursorko-lümfoblastne leukeemia-lümfoom - antineoplastilised ained - blincyto is indicated as monotherapy for the treatment of adults with cd19 positive relapsed or refractory b precursor acute lymphoblastic leukaemia (all). patients with philadelphia chromosome positive b-precursor all should have failed treatment with at least 2 tyrosine kinase inhibitors (tkis) and have no alternative treatment options. blincyto is indicated as monotherapy for the treatment of adults with philadelphia chromosome negative cd19 positive b-precursor all in first or second complete remission with minimal residual disease (mrd) greater than or equal to 0. blincyto is indicated as monotherapy for the treatment of paediatric patients aged 1 year or older with philadelphia chromosome negative cd19 positive b precursor all which is refractory or in relapse after receiving at least two prior therapies or in relapse after receiving prior allogeneic haematopoietic stem cell transplantation. blincyto is indicated as monotherapy for the treatment of paediatric patients aged 1 year or older with high-risk first relapsed philadelphia chromosome negative cd19 positive b-precursor all as part of the consolidation therapy (see section 4.

Estònia - estonià - Ravimiamet

glaxosmithkline (ireland) limited - lamotrigiin - närimis-/dispergeeruv tablett - 5mg 56tk; 5mg 50tk; 5mg 42tk; 5mg 60tk; 5mg 10tk

Estònia - estonià - Ravimiamet

glaxosmithkline (ireland) limited - lamotrigiin - närimis-/dispergeeruv tablett - 100mg 200tk; 100mg 42tk; 100mg 10tk; 100mg 30tk; 100mg 98tk; 100mg 14tk; 100mg 56tk

Estònia - estonià - Ravimiamet

glaxosmithkline (ireland) limited - lamotrigiin - närimis-/dispergeeruv tablett - 50mg 50tk; 50mg 90tk; 50mg 200tk; 50mg 10tk; 50mg 60tk; 50mg 98tk; 50mg 14tk; 50mg 100tk; 50mg 28tk

Estònia - estonià - Ravimiamet

desitin arzneimittel gmbh - karbamasepiin - toimeainet prolongeeritult vabastav tablett - 300mg 50tk; 300mg 100tk

Estònia - estonià - Ravimiamet

glaxosmithkline (ireland) limited - lamotrigiin - närimis-/dispergeeruv tablett - 25mg 42tk; 25mg 14tk; 25mg 30tk; 25mg 28tk; 25mg 56tk

Estònia - estonià - Ravimiamet

desitin arzneimittel gmbh - karbamasepiin - toimeainet prolongeeritult vabastav tablett - 150mg 50tk; 150mg 100tk

Estònia - estonià - Ravimiamet

glaxosmithkline (ireland) limited - lamotrigiin - närimis-/dispergeeruv tablett - 2mg 30tk

Estònia - estonià - Ravimiamet

desitin arzneimittel gmbh - karbamasepiin - toimeainet prolongeeritult vabastav tablett - 600mg 50tk; 600mg 100tk